APA (7th ed.) Citation

IH, H., BJ, B., ES, W., JR, W., KA, S., SE, C., & AE, W. (2001). Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivatives. Archiv der Pharmazie, 334(7), 229. https://doi.org/10.1002/1521-4184(200107)334:7<229::aid-ardp229>3.0.co;2-o

Chicago Style (17th ed.) Citation

IH, Hall, Barnes BJ, Ward ES, Wheaton JR, Shaffer KA, Cho SE, and Warren AE. "Targeting of Human Tmolt4 Leukemic Type II IMP Dehydrogenase by Cyclic Imide Related Derivatives." Archiv Der Pharmazie 334, no. 7 (2001): 229. https://doi.org/10.1002/1521-4184(200107)334:7<229::aid-ardp229>3.0.co;2-o.

MLA (9th ed.) Citation

IH, Hall, et al. "Targeting of Human Tmolt4 Leukemic Type II IMP Dehydrogenase by Cyclic Imide Related Derivatives." Archiv Der Pharmazie, vol. 334, no. 7, 2001, p. 229, https://doi.org/10.1002/1521-4184(200107)334:7<229::aid-ardp229>3.0.co;2-o.